fr en

Réactifs et instruments pour l'immunologie, la biologie cellulaire et la biologie moléculaire.

N-acetylcysteine amide [38520-57-9]

Imprimer

Référence NB-64-29934-1mL

Conditionnement : 1mLx10mM(inDMSO)

Contactez votre distributeur local :

Téléphone : +1 850 650 7790

Marque : Neo Biotech

Demander plus d'informations

Contactez votre distributeur local :

Téléphone : +1 850 650 7790

Remove All

N-acetylcysteine amide

Copy Product Info

Synonyms:

Catalog No. T5518 Copy Product Info

Purity: 99.98%

N-Acetylcysteine amide is a thiol antioxidant and a neuroprotective agent with cell permeability and blood-brain barrier permeability. N-Acetylcysteine amide reduces ROS production.

Cas No. 38520-57-9

For research use only—not for human use. No sales to individuals. Use as intended only.

Select Batch

Purity:99.98%

Appearance:Solid

Color:White

Product Introduction

Bioactivity

Description	N-Acetylcysteine amide is a thiol antioxidant and a neuroprotective agent with cell permeability and blood-brain barrier permeability. N-Acetylcysteine amide reduces ROS production.
In vitro	METHODS: Human esophageal cancer cells KYSE30 and KYSE150 were treated with LAT1-IN-1 (1-100 mM) for 3 days, and cell viability was measured by MTT assay. RESULTS: LAT1-IN-1 treatment inhibited cell proliferation in a dose-dependent manner. [1] METHODS: HTR8 SVneo, JEG-3 and JAR cells were treated with LAT1-IN-1 (0.1-4 µM) for 24 h, and the expression levels of target proteins were detected by Western Blot. RESULTS: LAT1 protein was significantly reduced after 24 h LAT1-IN-1 treatment, and LAT1-IN-1 could directly regulate the expression of LAT1. [2]
In vivo	METHODS: To assay antitumor activity in vivo, LAT1-IN-1 (200 mg/kg) was administered intravenously to BALB/c nude mice bearing KYSE150 tumors once daily for 14 days. RESULTS: Daily treatment with LAT1-IN-1 for 14 consecutive days significantly delayed tumor growth. [1]
Cell Research	To determine effectiveness of NACA and NAC in protection of H9c2 cells from DOX-induced toxicity, cells were treated with NACA or NAC at 0.75 mM for 2 h followed by exposure to freshly prepared cell culture medium with DOX in presence or absence of NACA or NAC at designated concentrations. The concentrations of DOX were 0.25 μM, 0.75 μM, 2 μM, 5 μM, 20 μM, and 100 μM. The exposure durations were 24 h, 48 h, or 48 h. Cells incubated with NACA or NAC alone were used as the control[1].
Animal Research	rats were randomly divided into three groups (n=6-8 animals/group): N-acetylcysteine amide?loaded pump (18.5?mg/kg/hr) and a single 150 mg/kg bolus intraperitoneal (IP) injection of NACA given (30 min post-injury) ?N-acetylcysteine amide?(18.5 mg/kg/hr) loaded pump and a single 150 mg/kg bolus injection of N-acetylcysteine amide?given IP (30 min post-injury) ?Vehicle loaded pump and?single vehicle bolus injection given IP (30 min post-injury).?Following random distribution of all animals into one of the three previous groups, experimenters were blinded to treatment group.?The osmotic mini pumps were assembled and implanted immediately after injury and remained in the animals for 7 days[2]

Chemical Properties

Molecular Weight	162.21
Formula	C₅H₁₀N₂O₂S
Cas No.	38520-57-9
Smiles	O=C(N)[C@@H](NC(C)=O)CS
Relative Density.	1.226 g/cm3 (Predicted)

Storage & Solubility Information

Storage

Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature.

Solubility Information

H2O: 100 mg/mL (616.48 mM), Sonication is recommended.

DMSO: 245 mg/mL (1510.39 mM), Sonication is recommended.

In Vivo Formulation

10% DMSO+40% PEG300+5% Tween 80+45% Saline: 5 mg/mL (30.82 mM), Sonication is recommended.

Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.

Solution Preparation Table

H2O/DMSO

	1mg	5mg	10mg	50mg
1 mM	6.1648 mL	30.8242 mL	61.6485 mL	308.2424 mL
5 mM	1.2330 mL	6.1648 mL	12.3297 mL	61.6485 mL
10 mM	0.6165 mL	3.0824 mL	6.1648 mL	30.8242 mL
20 mM	0.3082 mL	1.5412 mL	3.0824 mL	15.4121 mL
50 mM	0.1233 mL	0.6165 mL	1.2330 mL	6.1648 mL
100 mM	0.0616 mL	0.3082 mL	0.6165 mL	3.0824 mL

Note : The dilution table applies only to solid products. For liquid products, please calculate the stock solution based on the stated concentration and/or density.

Calculator

Molarity Calculator
Dilution Calculator
Reconstitution Calculator
Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:

For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, and a total of 10 animals are to be administered, using a formulation of 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH₂O , the resulting working solution concentration would be 2 mg/mL.

Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSO to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSO stock solution to 400 µL PEG300 and mix thoroughly until the solution becomes clear.

2) Add 50 µL Tween 80 and mix well until fully clarified.

3) Add 450 µL Saline,PBS or ddH₂O and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.

All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.

Dose Conversion

Keywords

ROSReactiveOxygenSpeciesReactive Oxygen SpeciesN-Acetylcysteine amideNacetylcysteine amideN acetylcysteine amideInhibitorinhibit

Related Tags: N-acetylcysteine amide chemical structure | N-acetylcysteine amide in vivo | N-acetylcysteine amide in vitro | N-acetylcysteine amide formula | N-acetylcysteine amide molecular weight